Combining a Mediterranean Diet With Physical Activity to Address Cardiometabolic Risk
MEx
Mediterranean Diet and Physical Activity: is the Whole Better Than the Sum of Each Part ? Clinical and Mechanistic Perspectives
1 other identifier
interventional
200
1 country
1
Brief Summary
There is little doubt scientifically that healthy eating, such as adhering to the Mediterranean diet (MedDiet) principles, is key for the prevention of cardiovascular disease (CVD). There is also convincing evidence for a strong inverse relationship between moderate intensity physical activity (PA) and mortality. Surprisingly, no study has yet formally documented how the combination of a MedDiet and regular PA improves cardiometabolic health in high-risk individuals. Why is this an important issue to address? On the one hand, a rigorous demonstration that the combination of a healthy diet and PA is better than the sum of each part in terms of cardiometabolic benefits will underpin the importance of advocating the combination of both modalities systematically to maximize health effects. Alternatively (and provocatively), results showing that healthy eating and PA have non-additive or non-synergistic effects will imply that one needs to adhere to only one of these two lifestyle modalities to maximizes cardiometabolic benefits. The overarching aim of this research is to test the hypothesis that consumption of a MedDiet combined with PA do act synergistically to improve cardiometabolic risk. The investigators hypothesize that healthy eating and PA act in synergy to reduce postprandial lipemia, a powerful independent risk factor for coronary heart disease.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Oct 2018
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 22, 2018
CompletedStudy Start
First participant enrolled
October 22, 2018
CompletedFirst Posted
Study publicly available on registry
November 6, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 24, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2023
CompletedJune 14, 2024
June 1, 2024
4.5 years
October 22, 2018
June 13, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
1. Serum 4-hour post-prandial TG concentrations
Serum TG concentrations (mmol/l) will be measured 4 hours after ingestion of a fatty meal (fat load), at the end of the 16-week intervention in all subjects in each group. The fat load will be conducted 48 hours after the last exercise training session in the PA groups (hence at 16.2 weeks, or 114 days). Analyses will be adjusted for 4-hr postprandial TG values measured at baseline.
16.3 week (114 days)
Secondary Outcomes (24)
Serum fasting TG concentrations
16 week (112 days)
Serum fasting TG concentrations
16.3 week (114 days)
Serum fasting LDL-C concentrations
16 week (112 days)
Serum fasting LDL-C concentrations
16.3 week (114 days)
Serum fasting HDL-C concentrations
16 week (112 days)
- +19 more secondary outcomes
Other Outcomes (2)
Change (week 0 vs week 16) in android obesity
week 0 and week 16 (112 days)
Gut microbiota
16 week (112 days)
Study Arms (4)
Mediterranean diet (MedDiet)
EXPERIMENTALPhysical activity (PA)
EXPERIMENTALMediterranean diet and physical activity
EXPERIMENTALControl
NO INTERVENTIONInterventions
Participants randomized in the Mediterranean diet group without physical activity will be instructed and supported towards adhering to principles of the Mediterranean diet, without changes in physical activity habits.
Participants randomized in the group physical activity without Mediterranean diet will participate in a structured, supervised PA program to achieve 150 min of moderate PA per week, without changes in dietary habits.
The combination group (MedDiet + PA) will receive the combination of both interventions.
Eligibility Criteria
You may qualify if:
- Waist circumference of 80 cm and over for women and 94 cm and over for men
- Serum triglyceride concentration of 1.5 mmol/L or higher
- For pre-menopausal women: regular cycle for at least 3 months, do not become pregnant or breastfeed
- For menopausal women: no hormone or stable dose for at least 6 months
You may not qualify if:
- Have a calculated Mediterranean score \> 25
- Do \> 100 minutes of moderate physical activity per week
- Weight change of \> 5 kg in the last 3 months
- Presence of familial hypercholesterolemia, diabetes, history of CVD
- Take medications that affect inflammation and blood lipids
- Have taken anti-diabetic agents in the last 6 months
- Smoker
- Alcohol consumption \>14 drinks per week
- Have allergies or aversions to components of the Mediterranean diet
- Follow a structured training program
- Dieting or having a special diet
- Inability to engage in a physical activity program
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Laval Universitylead
- Canadian Institutes of Health Research (CIHR)collaborator
Study Sites (1)
Institute of Nutrition and Funtional Foods
Québec, G1V 0A6, Canada
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Benoît Lamarche, PhD
Laval University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- FACTORIAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Study director
Study Record Dates
First Submitted
October 22, 2018
First Posted
November 6, 2018
Study Start
October 22, 2018
Primary Completion
April 24, 2023
Study Completion
December 31, 2023
Last Updated
June 14, 2024
Record last verified: 2024-06